 | • レポートコード：GIR-2104Z06486 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、グリコシル化ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。グリコシル化ペプチドの種類別市場規模（モノクローナル抗体（MAB）、エリスロポエチン（EPO）、その他）、用途別市場規模（腫瘍、造血系疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・グリコシル化ペプチドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sandoz International、Pfizer、Roche、Teva Pharmaceuticals Industries、Celltrion、Biocon、Dr.Reddys Laboratories、Medtronic、Cipla、Bachem Americas ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体（MAB）、エリスロポエチン（EPO）、その他 ・用途別分析2016年-2026年：腫瘍、造血系疾患、その他 ・グリコシル化ペプチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・グリコシル化ペプチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・グリコシル化ペプチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・グリコシル化ペプチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・グリコシル化ペプチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Glycosylated Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Glycosylated Peptide size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Glycosylated Peptide market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Glycosylated Peptide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies (MABs)
Erythropoietin (EPO)
Others
Market segment by Application can be divided into
Oncology
Blood Disorder
Others
The key market players for global Glycosylated Peptide market are listed below:
Sandoz International
Pfizer
Roche
Teva Pharmaceuticals Industries
Celltrion
Biocon
Dr.Reddys Laboratories
Medtronic
Cipla
Bachem Americas
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Glycosylated Peptide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glycosylated Peptide Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Erythropoietin (EPO)
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Glycosylated Peptide Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Blood Disorder
1.3.4 Others
1.4 Global Glycosylated Peptide Market Size & Forecast
1.4.1 Global Glycosylated Peptide Sales in Value (2016-2026))
1.4.2 Global Glycosylated Peptide Sales in Volume (2016-2026)
1.4.3 Global Glycosylated Peptide Price by Type (2016-2026) & (US$/Unit)
1.5 Global Glycosylated Peptide Production Capacity Analysis
1.5.1 Global Glycosylated Peptide Total Production Capacity (2016-2026)
1.5.2 Global Glycosylated Peptide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glycosylated Peptide Market Drivers
1.6.2 Glycosylated Peptide Market Restraints
1.6.3 Glycosylated Peptide Trends Analysis
2 Manufacturers Profiles
2.1 Sandoz International
2.1.1 Sandoz International Details
2.1.2 Sandoz International Major Business
2.1.3 Sandoz International Glycosylated Peptide Product and Services
2.1.4 Sandoz International Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Glycosylated Peptide Product and Services
2.2.4 Pfizer Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Glycosylated Peptide Product and Services
2.3.4 Roche Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Teva Pharmaceuticals Industries
2.4.1 Teva Pharmaceuticals Industries Details
2.4.2 Teva Pharmaceuticals Industries Major Business
2.4.3 Teva Pharmaceuticals Industries Glycosylated Peptide Product and Services
2.4.4 Teva Pharmaceuticals Industries Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Celltrion
2.5.1 Celltrion Details
2.5.2 Celltrion Major Business
2.5.3 Celltrion Glycosylated Peptide Product and Services
2.5.4 Celltrion Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Biocon
2.6.1 Biocon Details
2.6.2 Biocon Major Business
2.6.3 Biocon Glycosylated Peptide Product and Services
2.6.4 Biocon Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Dr.Reddys Laboratories
2.7.1 Dr.Reddys Laboratories Details
2.7.2 Dr.Reddys Laboratories Major Business
2.7.3 Dr.Reddys Laboratories Glycosylated Peptide Product and Services
2.7.4 Dr.Reddys Laboratories Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Medtronic
2.8.1 Medtronic Details
2.8.2 Medtronic Major Business
2.8.3 Medtronic Glycosylated Peptide Product and Services
2.8.4 Medtronic Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Glycosylated Peptide Product and Services
2.9.4 Cipla Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Bachem Americas
2.10.1 Bachem Americas Details
2.10.2 Bachem Americas Major Business
2.10.3 Bachem Americas Glycosylated Peptide Product and Services
2.10.4 Bachem Americas Glycosylated Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Glycosylated Peptide Sales by Manufacturer
3.1 Global Glycosylated Peptide Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Glycosylated Peptide Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Glycosylated Peptide
3.4 Market Concentration Rate
3.4.1 Top 3 Glycosylated Peptide Manufacturer Market Share
3.4.2 Top 6 Glycosylated Peptide Manufacturer Market Share
3.5 Global Glycosylated Peptide Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Glycosylated Peptide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glycosylated Peptide Market Size by Region
4.1.1 Global Glycosylated Peptide Sales in Volume by Region (2016-2026)
4.1.2 Global Glycosylated Peptide Revenue by Region (2016-2026)
4.2 North America Glycosylated Peptide Revenue (2016-2026)
4.3 Europe Glycosylated Peptide Revenue (2016-2026)
4.4 Asia-Pacific Glycosylated Peptide Revenue (2016-2026)
4.5 South America Glycosylated Peptide Revenue (2016-2026)
4.6 Middle East and Africa Glycosylated Peptide Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Glycosylated Peptide Sales in Volume by Type (2016-2026)
5.2 Global Glycosylated Peptide Revenue by Type (2016-2026)
5.3 Global Glycosylated Peptide Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Glycosylated Peptide Sales in Volume by Application (2016-2026)
6.2 Global Glycosylated Peptide Revenue by Application (2016-2026)
6.3 Global Glycosylated Peptide Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Glycosylated Peptide Sales by Type (2016-2026)
7.2 North America Glycosylated Peptide Sales by Application (2016-2026)
7.3 North America Glycosylated Peptide Market Size by Country
7.3.1 North America Glycosylated Peptide Sales in Volume by Country (2016-2026)
7.3.2 North America Glycosylated Peptide Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Glycosylated Peptide Sales by Type (2016-2026)
8.2 Europe Glycosylated Peptide Sales by Application (2016-2026)
8.3 Europe Glycosylated Peptide Market Size by Country
8.3.1 Europe Glycosylated Peptide Sales in Volume by Country (2016-2026)
8.3.2 Europe Glycosylated Peptide Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Glycosylated Peptide Sales by Type (2016-2026)
9.2 Asia-Pacific Glycosylated Peptide Sales by Application (2016-2026)
9.3 Asia-Pacific Glycosylated Peptide Market Size by Region
9.3.1 Asia-Pacific Glycosylated Peptide Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Glycosylated Peptide Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Glycosylated Peptide Sales by Type (2016-2026)
10.2 South America Glycosylated Peptide Sales by Application (2016-2026)
10.3 South America Glycosylated Peptide Market Size by Country
10.3.1 South America Glycosylated Peptide Sales in Volume by Country (2016-2026)
10.3.2 South America Glycosylated Peptide Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glycosylated Peptide Sales by Type (2016-2026)
11.2 Middle East & Africa Glycosylated Peptide Sales by Application (2016-2026)
11.3 Middle East & Africa Glycosylated Peptide Market Size by Country
11.3.1 Middle East & Africa Glycosylated Peptide Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Glycosylated Peptide Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Glycosylated Peptide Typical Distributors
12.3 Glycosylated Peptide Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Glycosylated Peptide Revenue by Type, (USD Million), 2021-2026
Table 2. Global Glycosylated Peptide Revenue by Application, (USD Million), 2021-2026
Table 3. Sandoz International Basic Information, Manufacturing Base and Competitors
Table 4. Sandoz International Major Business
Table 5. Sandoz International Glycosylated Peptide Product and Services
Table 6. Sandoz International Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Glycosylated Peptide Product and Services
Table 10. Pfizer Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Glycosylated Peptide Product and Services
Table 14. Roche Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Teva Pharmaceuticals Industries Basic Information, Manufacturing Base and Competitors
Table 16. Teva Pharmaceuticals Industries Major Business
Table 17. Teva Pharmaceuticals Industries Glycosylated Peptide Product and Services
Table 18. Teva Pharmaceuticals Industries Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Celltrion Basic Information, Manufacturing Base and Competitors
Table 20. Celltrion Major Business
Table 21. Celltrion Glycosylated Peptide Product and Services
Table 22. Celltrion Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Biocon Basic Information, Manufacturing Base and Competitors
Table 24. Biocon Major Business
Table 25. Biocon Glycosylated Peptide Product and Services
Table 26. Biocon Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dr.Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Dr.Reddys Laboratories Major Business
Table 29. Dr.Reddys Laboratories Glycosylated Peptide Product and Services
Table 30. Dr.Reddys Laboratories Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Medtronic Basic Information, Manufacturing Base and Competitors
Table 32. Medtronic Major Business
Table 33. Medtronic Glycosylated Peptide Product and Services
Table 34. Medtronic Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Cipla Basic Information, Manufacturing Base and Competitors
Table 36. Cipla Major Business
Table 37. Cipla Glycosylated Peptide Product and Services
Table 38. Cipla Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Bachem Americas Basic Information, Manufacturing Base and Competitors
Table 40. Bachem Americas Major Business
Table 41. Bachem Americas Glycosylated Peptide Product and Services
Table 42. Bachem Americas Glycosylated Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Glycosylated Peptide Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Glycosylated Peptide Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Glycosylated Peptide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Glycosylated Peptide Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Glycosylated Peptide Production Site of Key Manufacturer
Table 48. Global Glycosylated Peptide Sales by Region (2016-2021e) & (K Units)
Table 49. Global Glycosylated Peptide Sales by Region (2021-2026) & (K Units)
Table 50. Global Glycosylated Peptide Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Glycosylated Peptide Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Glycosylated Peptide Sales by Type (2016-2021e) & (K Units)
Table 53. Global Glycosylated Peptide Sales by Type (2021-2026) & (K Units)
Table 54. Global Glycosylated Peptide Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Glycosylated Peptide Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Glycosylated Peptide Price by Type (2016-2021e) & (US$/Unit)
Table 57. Global Glycosylated Peptide Price by Type (2021-2026) & (US$/Unit)
Table 58. Global Glycosylated Peptide Sales by Application (2016-2021e) & (K Units)
Table 59. Global Glycosylated Peptide Sales by Application (2021-2026) & (K Units)
Table 60. Global Glycosylated Peptide Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Glycosylated Peptide Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Glycosylated Peptide Price by Application (2016-2021e) & (US$/Unit)
Table 63. Global Glycosylated Peptide Price by Application (2021-2026) & (US$/Unit)
Table 64. North America Glycosylated Peptide Sales by Country (2016-2021e) & (K Units)
Table 65. North America Glycosylated Peptide Sales by Country (2021-2026) & (K Units)
Table 66. North America Glycosylated Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Glycosylated Peptide Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Glycosylated Peptide Sales by Type (2016-2021e) & (K Units)
Table 69. North America Glycosylated Peptide Sales by Type (2021-2026) & (K Units)
Table 70. North America Glycosylated Peptide Sales by Application (2016-2021e) & (K Units)
Table 71. North America Glycosylated Peptide Sales by Application (2021-2026) & (K Units)
Table 72. Europe Glycosylated Peptide Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Glycosylated Peptide Sales by Country (2021-2026) & (K Units)
Table 74. Europe Glycosylated Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Glycosylated Peptide Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Glycosylated Peptide Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Glycosylated Peptide Sales by Type (2021-2026) & (K Units)
Table 78. Europe Glycosylated Peptide Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Glycosylated Peptide Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Glycosylated Peptide Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Glycosylated Peptide Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Glycosylated Peptide Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Glycosylated Peptide Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Glycosylated Peptide Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Glycosylated Peptide Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Glycosylated Peptide Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Glycosylated Peptide Sales by Application (2021-2026) & (K Units)
Table 88. South America Glycosylated Peptide Sales by Country (2016-2021e) & (K Units)
Table 89. South America Glycosylated Peptide Sales by Country (2021-2026) & (K Units)
Table 90. South America Glycosylated Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Glycosylated Peptide Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Glycosylated Peptide Sales by Type (2016-2021e) & (K Units)
Table 93. South America Glycosylated Peptide Sales by Type (2021-2026) & (K Units)
Table 94. South America Glycosylated Peptide Sales by Application (2016-2021e) & (K Units)
Table 95. South America Glycosylated Peptide Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Glycosylated Peptide Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Glycosylated Peptide Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Glycosylated Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Glycosylated Peptide Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Glycosylated Peptide Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Glycosylated Peptide Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Glycosylated Peptide Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Glycosylated Peptide Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Glycosylated Peptide Typical Distributors
Table 107. Glycosylated Peptide Typical Customers
List of Figures
Figure 1. Glycosylated Peptide Picture
Figure 2. Global Glycosylated Peptide Sales Market Share by Type in 2020
Figure 3. Monoclonal Antibodies (MABs)
Figure 4. Erythropoietin (EPO)
Figure 5. Others
Figure 6. Global Glycosylated Peptide Sales Market Share by Application in 2020
Figure 7. Oncology
Figure 8. Blood Disorder
Figure 9. Others
Figure 10. Global Glycosylated Peptide Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Glycosylated Peptide Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Glycosylated Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Glycosylated Peptide Sales (2016-2026) & (K Units)
Figure 32. Global Glycosylated Peptide Production Capacity (2016-2026) & (K Units)
Figure 33. Global Glycosylated Peptide Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Glycosylated Peptide Market Drivers
Figure 35. Glycosylated Peptide Market Restraints
Figure 36. Glycosylated Peptide Market Trends
Figure 37. Global Glycosylated Peptide Sales Market Share by Manufacturer in 2020
Figure 38. Global Glycosylated Peptide Revenue Market Share by Manufacturer in 2020
Figure 39. Glycosylated Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Glycosylated Peptide Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Glycosylated Peptide Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Glycosylated Peptide Sales Market Share by Region (2016-2026)
Figure 43. Global Glycosylated Peptide Revenue Market Share by Region (2016-2026)
Figure 44. North America Glycosylated Peptide Revenue (2016-2026) & (USD Million)
Figure 45. Europe Glycosylated Peptide Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Glycosylated Peptide Revenue (2016-2026) & (USD Million)
Figure 47. South America Glycosylated Peptide Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Glycosylated Peptide Revenue (2016-2026) & (USD Million)
Figure 49. Global Glycosylated Peptide Sales Market Share by Type (2016-2026)
Figure 50. Global Glycosylated Peptide Revenue Market Share by Type (2016-2026)
Figure 51. Global Glycosylated Peptide Price by Type (2016-2026) & (US$/Unit)
Figure 52. Global Glycosylated Peptide Sales Market Share by Application (2016-2026)
Figure 53. Global Glycosylated Peptide Revenue Market Share by Application (2016-2026)
Figure 54. Global Glycosylated Peptide Price by Application (2016-2026) & (US$/Unit)
Figure 55. North America Glycosylated Peptide Sales Market Share by Country (2016-2026)
Figure 56. North America Glycosylated Peptide Revenue Market Share by Country (2016-2026)
Figure 57. North America Glycosylated Peptide Sales Market Share by Type (2016-2026)
Figure 58. North America Glycosylated Peptide Sales Market Share by Application (2016-2026)
Figure 59. Europe Glycosylated Peptide Sales Market Share by Country (2016-2026)
Figure 60. Europe Glycosylated Peptide Revenue Market Share by Country (2016-2026)
Figure 61. Europe Glycosylated Peptide Sales Market Share by Type (2016-2026)
Figure 62. Europe Glycosylated Peptide Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Glycosylated Peptide Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Glycosylated Peptide Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Glycosylated Peptide Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Glycosylated Peptide Sales Market Share by Application (2016-2026)
Figure 67. South America Glycosylated Peptide Sales Market Share by Country (2016-2026)
Figure 68. South America Glycosylated Peptide Revenue Market Share by Country (2016-2026)
Figure 69. South America Glycosylated Peptide Sales Market Share by Type (2016-2026)
Figure 70. South America Glycosylated Peptide Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Glycosylated Peptide Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Glycosylated Peptide Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Glycosylated Peptide Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Glycosylated Peptide Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の糖化ヘモグロビン・C-ペプチド市場 2021：企業別、地域別、種類・用途別 The Glycosylated Hemoglobin and C-Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 世界のグリコシル化バイオシミラー市場規模・現状・予測（2021年-2027年） Glycosylated Biosimilars include mA, EPO etc in this report. Market Analysis and Insights: Global Glycosylated Biosimilars Market The global Glycosylated Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industr…
- 世界の組換え非グリコシル化タンパク質バイオシミラー市場規模・現状・予測（2021年-2027年） Recombinant non-glycosylated proteins include human growth hormone, granulocyte colony-stimulating factor, interferons, and insulin. The statistic scope in this report is Recombinant non-glycosylated proteins biosimilars. Market Analysis and Insights: Global Recombinant Non-Glycosylated Proteins Bio…
- 世界のペプチドベース胃腸障害治療薬市場規模・現状・予測（2021年-2027年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…
- 世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …